Welcome to our dedicated page for Afya news (Ticker: AFYA), a resource for investors and traders seeking the latest updates and insights on Afya stock.
Afya Limited (AFYA) delivers essential medical education and digital health solutions across Brazil through its integrated network and technology platforms. This news hub provides investors and healthcare professionals with centralized access to corporate developments, strategic initiatives, and operational updates.
Track official press releases covering financial results, academic partnerships, technology implementations, and regulatory milestones. Our curated collection includes updates on Afya's three core segments: Undergraduate medical programs, Continuing Education certifications, and Digital Services supporting clinical decision-making.
Key updates feature expansion of educational partnerships, digital tool enhancements for healthcare providers, and growth metrics across Afya's learning platforms. Users benefit from chronological organization of material events and strategic announcements without editorial commentary.
Bookmark this page for streamlined monitoring of Afya's progress in merging traditional medical training with innovative digital solutions. Verify publication dates and consult original filings for complete context on all developments.
Afya Limited (AFYA) has acquired Glic, a diabetes care app, through its subsidiary Afya Participações S.A. The purchase, valued at R$22 million in cash, aims to enhance Afya's digital services strategy. Glic boasts over 90,000 active users and 1,100 physicians, projecting gross revenues of R$3.7 million for 2022. An additional earn-out of up to R$12 million is contingent upon achieving specific revenue targets in 2023 and 2024. This acquisition strengthens Afya's position in the physician-patient relationship sector.
Afya Limited (Nasdaq: AFYA), a leader in medical education and digital health services in Brazil, reported a strong Q1 2022, with adjusted net revenue rising 41.0% to R$567.7 million, and adjusted EBITDA growing 30.4% to R$270.8 million, despite a decreased EBITDA margin of 47.7%. Net income reached R$134.9 million, a 19.1% increase YoY. Afya reaffirmed its full-year guidance for 2022, targeting adjusted net revenue between R$2.28 billion and R$2.36 billion, alongside strategic acquisitions to bolster its digital ecosystem. The company also demonstrated commitment to ESG initiatives.
Afya Limited (NASDAQ: AFYA) announced the closing of a transaction where Bertelsmann acquired 6,000,000 Class B shares at US$26.90 each, granting Bertelsmann a ~57.5% voting interest. The company has also extended CEO Virgilio Gibbon's contract through May 2027 to support its expansion in medical education and digital health strategies. Additionally, Benedikt Dalkmann was appointed to the board to enhance leadership diversity.
Afya Limited (AFYA) held its Annual General Meeting on April 12, 2022, where key resolutions were approved. This included the ratification of financial statements for the fiscal year ending December 31, 2021, and the approval of the Amended and Restated Memorandum and Articles of Association. These changes are subject to closing a transaction disclosed on March 4, 2022, between the Esteves Family and Bertelsmann SE & Co. KGaA. Further details are available on their website.
Afya Limited (NASDAQ: AFYA) announced that Bertelsmann SE & Co. KGaA will purchase 6,000,000 Class B shares at US$26.90 each. This transaction follows a prior disclosure on March 7, 2022. After the deal, Bertelsmann will hold a 57.5% voting interest, while the Esteves Family will control 33.1%. The anticipated closing date for the transaction is May 4, 2022, pending standard closing conditions. This move strengthens Bertelsmann's and the Esteves Family's influence over Afya's decision-making processes.
Afya Limited (NASDAQ: AFYA) announced the resignation of Mr. Paulo Passoni from its Board of Directors, effective immediately. He has been a board member since May 2021. Mrs. Maria Tereza Azevedo has been appointed as his successor, bringing extensive experience in investment and corporate finance from her roles at Softbank, Santander, and UBS. This change aims to enhance the board's diversity and strategic decision-making capabilities, with Azevedo's expertise in the education sector being particularly valuable for Afya's growth.
Afya Limited (NASDAQ: AFYA) will announce its first-quarter 2022 financial results for the period ended March 31, 2022, on May 23, 2022, after market close. A conference call and webcast are scheduled for 5:00 PM EDT, providing insights into the company's performance. Afya is a prominent medical education group in Brazil, known for its extensive medical school offerings and a comprehensive ecosystem for medical students and professionals, enhancing their educational journey and professional development.
Afya Limited (NASDAQ: AFYA) is set to hold its Annual General Meeting (AGM) on April 29, 2022, at 11:00 AM Brasília time, both in-person and virtually. Key resolutions include the approval of the financial statements for the fiscal year ended December 31, 2021, and amendments to the Memorandum and Articles of Association following a transaction with Bertelsmann SE & Co. KGaA. Shareholders on record as of April 7, 2022, are eligible to participate and vote. The company emphasizes the importance of shareholder participation in decision-making.
Afya Limited (NASDAQ: AFYA) has announced the acquisition of 100% of CardioPapers for an enterprise value of R$35.0 million, paid in cash. CardioPapers is a leading medical content and education platform in Cardiology, offering over ten courses and engaging nearly 215,000 followers on Instagram. The platform generated R$18.8 million in gross revenue for 2022. Additional earn-out payments of up to R$15 million may be made based on revenue and other goals for 2023 and 2024. This acquisition is expected to enhance Afya's digital ecosystem and capabilities in medical education.
FAQ
What is the current stock price of Afya (AFYA)?
What is the market cap of Afya (AFYA)?
